<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Mid Day Module (Pyqs, Mixed Bag 15)   2025 03 25</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Mid Day Module (Pyqs, Mixed Bag 15)   2025 03 25</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                40 Questions | 160 Total Marks | 50 min Duration | ~75.0 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 40 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 50 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 40</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Mid Day Module (Pyqs, Mixed Bag 15)   2025 03 25 - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 40</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 40 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A patient presents with itching in the axilla. On microscopic examination of the skin scrapings, a red pigment-producing fungus with pencil-shaped macroconidia is seen. Which of the following is the most likely organism? (NEET PG 2022)", "options": [{"label": "A", "text": "Trichophyton violaceum", "correct": false}, {"label": "B", "text": "ï»¿ï»¿ï»¿Trichophyton rubrum", "correct": true}, {"label": "C", "text": "ï»¿ï»¿ï»¿Trichophyton tonsurans", "correct": false}, {"label": "D", "text": "ï»¿ï»¿ï»¿Trichophyton schoenleinii", "correct": false}], "correct_answer": "B. ï»¿ï»¿ï»¿Trichophyton rubrum", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/1_Al5ajjo.jpg"], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/1_fdWZk03.jpg", "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/1_LQbUupb.jpg", "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/1_dl4URiF.jpg", "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/19_1RQiVSh.jpg"], "explanation": "<p><strong>Ans. B) Trichophyton rubrum</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Trichophyton rubrum is identified by its red pigment-producing, velvety colonies with characteristic pencil-shaped macroconidia, making it the causative agent of various dermatophyte infections including tinea corporis that could present with itching in the axilla. Understanding the colony morphology and microscopic features is crucial for accurate identification and appropriate treatment of dermatophyte infections.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A girl presents with short stature, webbed neck, thick calves, shield -shaped chest, swelling of the ankle, and increased carrying angle. What is the likely diagnosis? (NEET PG 2021)", "options": [{"label": "A", "text": "Turner syndrome", "correct": true}, {"label": "B", "text": "Down syndrome", "correct": false}, {"label": "C", "text": "Patau syndrome", "correct": false}, {"label": "D", "text": "Edward syndrome", "correct": false}], "correct_answer": "A. Turner syndrome", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-30%20195617.jpg"], "explanation": "<p><strong>Ans. A) Turner syndrome</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Turner syndrome is characterized by features such as short stature, webbed neck, shield-shaped chest, peripheral lymphedema, and increased carrying angle, among other physical manifestations. It is caused by complete or partial monosomy of the X chromosome in phenotypic females.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient reports to the OPD with complaints of fatigue and pallor. Investigations indicated hemoglobin of 5.9 g/dL, increased RDW, increased total iron binding capacity, and low ferritin. The peripheral smear shows microcytosis. What is the likely diagnosis? ( FMGE Jan 2024)", "options": [{"label": "A", "text": "Iron deficiency anemia", "correct": true}, {"label": "B", "text": "Hemolytic anemia", "correct": false}, {"label": "C", "text": "Megaloblastic anemia", "correct": false}, {"label": "D", "text": "Sideroblastic anemia", "correct": false}], "correct_answer": "A. Iron deficiency anemia", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-152957.png"], "explanation": "<p><strong>Ans. A) Iron deficiency anemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ The patient presents with symptoms of fatigue and pallor, which are common findings in anemia. The investigations reveal a low hemoglobin level of 5.9 g/dL, indicating the presence of anemia. The increased red cell distribution width (RDW) suggests anisocytosis, or variation in the size of red blood cells.</li><li>â€¢ The increased total iron binding capacity (TIBC) and low ferritin levels indicate a deficiency in iron stores. Additionally, the peripheral smear shows microcytosis, which means the presence of small, hypochromic red blood cells. These findings are characteristic of iron deficiency anemia.</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option B. Hemolytic anemia is incorrect because these patients typically have an increased mean corpuscular volume (MCV) due to the premature destruction of red blood cells and the release of larger, immature cells into the circulation.</li><li>â€¢ Option B.</li><li>â€¢ Option C. Megaloblastic anemia is incorrect because it is characterized by the presence of large, macrocytic red blood cells, rather than the small, microcytic cells seen in this case.</li><li>â€¢ Option C.</li><li>â€¢ Option D. Sideroblastic anemia is incorrect because it is typically associated with elevated ferritin levels due to increased iron storage, whereas this patient has low ferritin levels.</li><li>â€¢ Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Iron deficiency anemia is characterized by low hemoglobin, increased RDW, increased TIBC, low ferritin, and the presence of microcytic red blood cells on peripheral smear.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Cowdry Type A inclusions are seen in? (NEET PG 2019)", "options": [{"label": "A", "text": "Herpes simplex", "correct": true}, {"label": "B", "text": "Rabies", "correct": false}, {"label": "C", "text": "Molluscum contagiosum", "correct": false}, {"label": "D", "text": "Adenovirus", "correct": false}], "correct_answer": "A. Herpes simplex", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/24/screenshot-2024-06-24-163153.png"], "explanation": "<p><strong>Ans. A) Herpes simplex</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Inclusion bodies produced in viral infection:</li><li>âž¤ Inclusion bodies produced in viral infection:</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The vector shown in the image below transmits which of the following organism? ( INICET MAY 2023)", "options": [{"label": "A", "text": "Orientia tsutsugamushi", "correct": true}, {"label": "B", "text": "Kyasanur forest disease", "correct": false}, {"label": "C", "text": "Chandipura virus", "correct": false}, {"label": "D", "text": "Anaplasma", "correct": false}], "correct_answer": "A. Orientia tsutsugamushi", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256120_page_8.jpg"], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256120_page_9_GIdqneC.jpg", "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256120_page_10.jpg", "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256120_page_11.jpg"], "explanation": "<p><strong>Ans. A) Orientia tsutsugamushi</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ The trombiculid mite, particularly in its larval stage called a chigger, transmits Orientia tsutsugamushi, the causative agent of scrub typhus.</li><li>âž¤ The trombiculid mite, particularly in its larval stage called a chigger, transmits Orientia tsutsugamushi, the causative agent of scrub typhus.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 6-year-old child presents to the emergency department with sudden onset of palpitations, shortness of breath, and dizziness. The child has no significant past medical history. On examination, the heart rate is 220 beats per minute, blood pressure is 90/60 mmHg, and the child appears anxious but is otherwise stable. An ECG confirms the diagnosis of paroxysmal supraventricular tachycardia (PSVT). What is the initial recommended dose of adenosine for this child? (NEET PG 2024)", "options": [{"label": "A", "text": "0.1 mg/kg", "correct": true}, {"label": "B", "text": "0.2 mg/kg", "correct": false}, {"label": "C", "text": "0.5 mg/kg", "correct": false}, {"label": "D", "text": "1.0 mg/kg", "correct": false}], "correct_answer": "A. 0.1 mg/kg", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) 0.1 mg/kg</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ The initial recommended dose of adenosine for treating PSVT in children is 0.1 mg/kg, with a maximum dose of 6 mg. If the initial dose is ineffective, a higher dose of 0.2 mg/kg may be administered.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "What is the antigen present in the recombinant HPV vaccine? (INICET NOV 2023)", "options": [{"label": "A", "text": "E1 + E2", "correct": false}, {"label": "B", "text": "E6 + E7", "correct": false}, {"label": "C", "text": "L1", "correct": true}, {"label": "D", "text": "L2", "correct": false}], "correct_answer": "C. L1", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) L1</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ The recombinant HPV vaccine primarily includes the L1 protein, which self-assembles into virus-like particles, providing the basis for immune recognition without causing the disease.</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. E1 + E2: E1 and E2 are early viral proteins, not included in vaccines due to their role in viral replication.</li><li>â€¢ Option A. E1 + E2:</li><li>â€¢ Option B. E6 + E7: E6 and E7 are proteins involved in oncogenesis, not appropriate for vaccine development.</li><li>â€¢ Option B. E6 + E7:</li><li>â€¢ Option D. L2: L2 is also a capsid protein but not the primary antigen used in current HPV vaccines.</li><li>â€¢ Option D. L2:</li><li>â€¢ Educational objective:</li><li>â€¢ Educational objective:</li><li>â€¢ The L1 protein of HPV forms the basis of the recombinant HPV vaccine, effectively stimulating an immune response by mimicking the virus structure.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following anti-diabetic drugs can increase glucose excretion in urine? (FMGE JANUARY 2024)", "options": [{"label": "A", "text": "Glimepiride", "correct": false}, {"label": "B", "text": "Liraglutide", "correct": false}, {"label": "C", "text": "Acarbose", "correct": false}, {"label": "D", "text": "Empagliflozin", "correct": true}], "correct_answer": "D. Empagliflozin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) Empagliflozin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Empagliflozin is an SGLT2 inhibitor .</li><li>â€¢ an SGLT2 inhibitor</li><li>â€¢ Drugs in this class (such as empagliflozin, canagliflozin, and dapagliflozin) inhibit the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, leading to increased glucose excretion in the urine (glycosuria). This helps lower blood glucose levels.</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Glimepiride: A sulfonylurea that stimulates insulin release from the pancreas.</li><li>â€¢ Option A. Glimepiride:</li><li>â€¢ Option B. Liraglutide: A GLP-1 receptor agonist that increases insulin secretion, slows gastric emptying, and promotes satiety.</li><li>â€¢ Option B. Liraglutide:</li><li>â€¢ Option C. Acarbose: An alpha-glucosidase inhibitor that delays carbohydrate absorption in the intestines, leading to increased excretion of undigested carbohydrates in the stools.</li><li>â€¢ Option C. Acarbose:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Empagliflozin, an SGLT2 inhibitor, increases glucose excretion in the urine by inhibiting the sodium-glucose co-transporter 2 in the kidneys.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "When is dilatation and curettage contraindicated? (NEET PG 2018)", "options": [{"label": "A", "text": "Pelvic inflammatory disease", "correct": true}, {"label": "B", "text": "Ectopic pregnancy", "correct": false}, {"label": "C", "text": "Menstrual irregularities", "correct": false}, {"label": "D", "text": "Endometriosis", "correct": false}], "correct_answer": "A. Pelvic inflammatory disease", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) Pelvic inflammatory disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Pelvic inflammatory disease (PID) includes endometritis, salpingitis, oophoritis, and parametritis. Any interventions like dilatation and curettage (D&C) are contraindicated in active PID due to the risk of exacerbating the infection and causing further complications.</li><li>â€¢ Other options:</li><li>â€¢ Other options:</li><li>â€¢ Option B. Ectopic pregnancy : D&C is not contraindicated in ectopic pregnancy; however, it is not typically performed in its management as it does not provide any benefit for this condition.</li><li>â€¢ Option B. Ectopic pregnancy</li><li>â€¢ Option C. Menstrual irregularities : D&C can be performed to obtain an endometrial biopsy in peri-menopausal women with abnormal uterine bleeding (AUB) if there are no other identifiable causes and if endometrial hyperplasia or malignancy is suspected.</li><li>â€¢ Option C. Menstrual irregularities</li><li>â€¢ Option D. Endometriosis : D&C is not usually performed solely for endometriosis unless there is an associated AUB that needs to be evaluated or treated.</li><li>â€¢ Option D. Endometriosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Dilatation and curettage (D&C) is contraindicated in active pelvic inflammatory disease (PID) due to the risk of spreading the infection</li><li>âž¤ Ref: Page 168, DC Duttaâ€™s Textbook of Gynecology, 6 th edition</li><li>âž¤ Ref: Page 168, DC Duttaâ€™s Textbook of Gynecology, 6 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 52-year-old female presents with metastatic breast cancer. She has previously undergone treatment with surgery, radiation, and multiple lines of chemotherapy, but her disease has progressed. Genetic testing reveals a BRCA1 mutation, indicating an impaired DNA repair mechanism. Her cancer is classified as HER2-negative and hormone receptor-positive. Given the genetic findings, her oncologist considers using a therapy that targets the PARP enzyme to exploit the DNA repair vulnerability of her cancer cells. Which of the following drugs would be appropriate to prescribe as a PARP inhibitor in this patient? (INICET NOV 2024)", "options": [{"label": "A", "text": "Palbociclib", "correct": false}, {"label": "B", "text": "Rucaparib", "correct": true}, {"label": "C", "text": "Vorinostat", "correct": false}, {"label": "D", "text": "Ustekinumab", "correct": false}], "correct_answer": "B. Rucaparib", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-08%20115210.jpg"], "explanation": "<p><strong>Ans. B) Rucaparib</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Rucaparib is a PARP (Poly ADP-Ribose Polymerase) inhibitor. PARP inhibitors work by blocking DNA repair mechanisms in cancer cells. In patients with BRCA mutations (who already have impaired DNA repair), PARP inhibition leads to synthetic lethality and cell death. The name helps identify PARP inhibitors as they end in \"parib\" (from Poly ADP-Ribose Polymerase inhibitor).</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Palbociclib: Incorrect. This is a cyclin-dependent kinase (CDK) 4/6 inhibitor used in hormone receptor-positive breast cancer. While it might be useful in this patient